Expertise in
49
conditions

Dr. David N. Oubre

Oncology
Pontchartrain Hematology And Oncology
120 Lakeview Cir, 
Covington, LA 
Accepting New Patients
Expertise in
49
conditions
Pontchartrain Hematology And Oncology
120 Lakeview Cir, 
Covington, LA 

Overview

David Oubre is an Oncologist practicing medicine in Covington, Louisiana.

Dr. Oubre is highly rated in 49 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Thrombocytopenia, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials. Dr. Oubre is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in LA

Hospital Affiliations

East Jefferson General Hospital
St Helena Parish Hospital
Hood Memorial Hospital
St Tammany Parish Hospital
North Oaks Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Pontchartrain Hematology and Oncology
120 Lakeview Cir, Covington, LA 70433

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Cisplatin, Carboplatin, Avelumab
Study Phase: Phase 2
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3
A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
Enrollment Status: Terminated
Publish Date: February 02, 2024
Intervention Type: Drug, Biological
Study Drugs: OSE2101, Docetaxel, Pemetrexed
Study Phase: Phase 3
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: September 21, 2022
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: Telaglenastat, Carboplatin Chemotherapy, Pemetrexed Chemotherapy, Pembrolizumab Immunotherapy, Dexamethasone
Study Phase: Phase 2
View 4 Less Clinical Trials

2 Total Publications

Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study.
Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study.
Journal: Breast cancer research and treatment
Published: June 24, 2023
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required
Before you request

St. Tammany Cancer Center - A Campus Of Ochsner Medical Center

900 Ochsner Blvd, 
Covington, LA 
 (4.4 miles away)
985-249-2383
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Patricia Braly is an Oncologist practicing medicine in Covington, Louisiana. Dr. Braly is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, and Ovarian Carcinosarcoma. Dr. Braly is board certified in American Board Of Obstetrics And Gynecology - Medical Oncology and American Board Of Obstetrics And Gynecology - Obstetrics & Gynecology. Dr. Braly is currently accepting new patients.

Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required
Before you request

St. Tammany Cancer Center - A Campus Of Ochsner Medical Center

900 Ochsner Blvd, 
Covington, LA 
 (4.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Suma Satti is an Oncologist practicing medicine in Covington, Louisiana. Dr. Satti is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Small Cell Lung Cancer (SCLC). Dr. Satti is board certified in American Board Of Internal Medicine - Hematology/Oncology. Dr. Satti is currently accepting new patients.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Ochsner Medical Center - New Orleans

1514 Jefferson Highway, 
New Orleans, LA 
 (31.3 miles away)
504-842-3910
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Marc Matrana is an Oncologist practicing medicine in New Orleans, Louisiana. Dr. Matrana is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Lung Cancer, Adult Soft Tissue Sarcoma, and Nephrectomy. Dr. Matrana is board certified in American Board Of Internal Medicine - Hematology/Oncology and American Board Of Internal Medicine - Internal Medicine. Dr. Matrana is currently accepting new patients.

Frequently Asked Questions about Dr. David N. Oubre

How do I make an appointment with Dr. David N. Oubre?

You can book an appointment with Dr. David N. Oubre by calling their office at 985-875-1202. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David N. Oubre a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David N. Oubre is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David N. Oubre specialize in?

While Dr. David N. Oubre is a Oncology, they have specific expertise in Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. David N. Oubre participate in research or clinical trials?

Yes. Dr. David N. Oubre has published 2 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. David N. Oubre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David N. Oubre accept my insurance?

Dr. David N. Oubre accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 985-875-1202 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Oubre's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 40 Advanced Conditions
    View All 83 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile